Shantha Biotechnics India

Shantha was created in 1993 by Dr. Varaprasad Reddy and is based in Hyderabad, India. Shantha develops, manufactures and markets several vaccines. It operates at international standards in a state-of-the-art facility. Shantha works with supranational organizations like UNICEF and PAHO to supply major international markets including Asia-Pacific, Africa and Latin America. In 1997, Shantha launched SHANVAC-Bâ„¢, the first recombinant Hepatitis B vaccine produced in India. SHANVAC-Bâ„¢, SHANTETRAâ„¢ (combination vaccine of Diphteria, Pertussis, Tetanus and Hepatitis B), SHAN5â„¢ (combination vaccine of Diphteria, Pertussis, Tetanus, Haemophilus influenza B and Hepatitis B) and SHANTTâ„¢ (Tetanus toxoid vaccine) are prequalified by the World Health Organization for supplying to United Nation agencies globally. Shantha also has an important portfolio of vaccines in development.